November 17th, 2013
Remaking the Heart: Stem Cells, Patches, Scaffolds, and More
Vimal Ramjee, MD
Which advance in regenerative cardiovascular biology has the best chance of being translated into a clinical treatment? A cardiology Fellow ponders cutting-edge science presentations at AHA.13.
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?